| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee3727dba91e4e7aa3b26ce9efbcc21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C243-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 |
| filingDate |
2001-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f923648d0c8fd2ee49ff082f08bf9780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d7351d1d8a7b1d84a7d9a1d6c36991
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c48080b08826b67474f892c247589542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda6b1a6c5a4af810117ff923727e382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9920c9c9d25baed3b2cb83917cf607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5836f59a52fa2bef56d93180985a073 |
| publicationDate |
2007-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7285547-B2 |
| titleOfInvention |
Amidinophenylalanine derivatives as thrombin inhibitors |
| abstract |
The compounds of the formula (formula 1) and pharmaceutically acceptable salts thereof and a process for preparing the same and pharmaceutical compositions containing the same are described wherein the substituents have the meaning as specified in the description. The compounds are used as thrombon inhibitors. |
| priorityDate |
2000-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |